Alper Turkel
Eskisehir, 26080, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.
Journal: Current oncology (Toronto, Ont.)
Published: May 02, 2026
Distinct fatigue profiles and psychological mechanisms among breast cancer survivors: A latent profile and mediation analysis.
Journal: Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi
Published: December 01, 2025
PRR11 expression in early ER+/HER2-low breast cancer: Association with estrogen receptor positivity and exploratory analysis of prognostic significance.
Journal: Oncology letters
Published: September 25, 2025
Investigation of the prevalence of HER2-ultralow and the effects of HER2 status (HER2-null vs. HER2-ultralow) on survival in HER2-negative early-stage breast cancer.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: September 07, 2025
Survival Outcomes and Recurrence Patterns of Early-Stage HER2-Positive Breast Cancer Patients on Adjuvant T-DM1 Treatment: Turkish Oncology Group (TOG) Study.
Journal: Clinical breast cancer
Published: September 07, 2025
Predictors of burnout and secondary traumatic stress in medical oncologists: the role of empathy and dispositional mindfulness.
Journal: BMC health services research
Published: September 02, 2025
Real-world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple-negative breast cancer: A multicenter study by the Turkish Oncology Group.
Journal: International journal of cancer
Published: July 31, 2025
Unilateral facial nerve paralysis following prolonged weekly paclitaxel therapy: a rare case of cranial neurotoxicity with diagnostic challenges.
Journal: Journal of chemotherapy (Florence, Italy)
Published: July 28, 2025
The Prognostic Impact of HER2 Status and Survival Outcomes in Metastatic Triple Negative Breast Cancer.
Journal: In vivo (Athens, Greece)
Published: July 25, 2025
"Pre-Treatment" and "Post-Treatment" Systemic Inflammatory Markers: Is There Any Prognostic Role for Metastatic Cervical Cancer on Bevacizumab Containing Treatment?
Journal: Medicina (Kaunas, Lithuania)
Published: April 10, 2025
Last Updated: 09/26/2026